Telomerase reverse 1 transcriptase promoter mutations identify a genomically defined and highly aggressive human pleural mesothelioma subgroup [Elektronski vir]Pirker, Christine ...Purpose: Human malignant pleural mesothelioma (MPM) is characterized by dismal prognosis. Consequently, dissection of molecular mechanisms driving malignancy is of key importance. Here we investigate ... whether activating mutations in the telomerase reverse transcriptase (TERT) gene promoter are present in MPM and associated with disease progression, cell immortalization, and genomic alteration patterns. Experimental Design: TERT promoters were sequenced in 182 MPM samples and compared with clinicopathologic characteristics. Surgical specimens from 45 patients with MPM were tested for in vitro immortalization. The respective MPM cell models (N = 22) were analyzed by array comparative genomic hybridization, gene expression profiling, exome sequencing as well as TRAP, telomere length, and luciferase promoter assays. Results: TERT promoter mutations were detected in 19 of 182 (10.4%) MPM cases and significantly associated with advanced disease and nonepithelioid histology. Mutations independently predicted shorter overall survival in both histologic MPM subtypes. Moreover, 9 of 9 (100%) mutated but only 13 of 36 (36.1%) wild-type samples formed immortalized cell lines. TERT promoter mutations were associated with enforced promoter activity and TERT mRNA expression, while neither telomerase activity nor telomere lengths were significantly altered. TERT promoter-mutated MPM cases exhibited distinctly reduced chromosomal alterations and specific mutation patterns. While BAP1 mutations/deletions were exclusive with TERT promoter mutations, homozygous deletions at the RBFOX1 and the GSTT1 loci were clearly enriched in mutated cases. Conclusions: TERT promoter mutations independently predict a dismal course of disease in human MPM. The altered genomic aberration pattern indicates that TERT promoter mutations identify a novel, highly aggressive MPM subtype presumably based on a specific malignant transformation process.Vir: Clinical cancer research [Elektronski vir]. - ISSN 1557-3265 (Vol. 26, iss. 14, 2020, str. 1-34)Vrsta gradiva - e-članek ; neleposlovje za odrasleLeto - 2020Jezik - angleškiCOBISS.SI-ID - 38561539
Pirker, Christine | Bilecz, Agnes | Grusch, Michael | Mohr, Thomas, onkolog | Heidenreich, Barbara, 1987- | Laszlo, Viktoria | Stockhammer, Paul | Lötsch, Daniela | Gojo, Johannes | Gabler, Lisa | Mohorčič, Katja, 1978- | Kern, Izidor
Vnos na polico
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Baze podatkov, v katerih je revija indeksirana
|Ime baze podatkov||Področje||Leto|
|Povezave do osebnih bibliografij avtorjev||Povezave do podatkov o raziskovalcih v sistemu SICRIS|
|Mohr, Thomas, onkolog|
|Heidenreich, Barbara, 1987-|
|Mohorčič, Katja, 1978-||30985|
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Gesla v Splošnem geslovniku COBISS
Prosimo, počakajte trenutek.